{"title":"基于基础标志物表达(EGFR和/或CK5/6)的五标志物小组在预测乳腺癌分子亚型预后方面优于三标志物小组吗?比较研究","authors":"P. Trivedi, Priyanka Singh","doi":"10.9734/bpi/rdmmr/v11/14345d","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":197171,"journal":{"name":"Recent Developments in Medicine and Medical Research Vol. 11","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study\",\"authors\":\"P. Trivedi, Priyanka Singh\",\"doi\":\"10.9734/bpi/rdmmr/v11/14345d\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":197171,\"journal\":{\"name\":\"Recent Developments in Medicine and Medical Research Vol. 11\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent Developments in Medicine and Medical Research Vol. 11\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/bpi/rdmmr/v11/14345d\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent Developments in Medicine and Medical Research Vol. 11","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/rdmmr/v11/14345d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study